| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers VWY Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ... Cancer discovery 3 (7), 761-769, 2013 | 648 | 2013 |
| Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus … DC Ling, BV Chapman, J Kim, GW Choby, P Kabolizadeh, DA Clump, ... Oral oncology 61, 41-46, 2016 | 95 | 2016 |
| Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation TT Sims, MB El Alam, TV Karpinets, S Dorta-Estremera, VL Hegde, ... Communications biology 4 (1), 237, 2021 | 80 | 2021 |
| The insurance approval process for proton radiation therapy: a significant barrier to patient care MS Ning, DR Gomez, AK Shah, CR Kim, MB Palmer, NG Thaker, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 724-733, 2019 | 57 | 2019 |
| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013; 3: 761–769. doi: 10.1158/2159-8290 VW Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ... CD-13-0103.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 56 | |
| Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis W Wei, L Lampe, S Park, BS Vangara, GS Waldo, S Cabantous, ... PloS one 7 (12), e50736, 2012 | 49 | 2012 |
| MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer BV Chapman, AI Wald, P Akhtar, AC Munko, J Xu, SP Gibson, JR Grandis, ... BMC cancer 15, 1-10, 2015 | 44 | 2015 |
| Adjuvant radiation therapy for margin-positive vulvar squamous cell carcinoma: defining the ideal dose-response using the National Cancer Data Base BV Chapman, BS Gill, AN Viswanathan, GK Balasubramani, ... International Journal of Radiation Oncology* Biology* Physics 97 (1), 107-117, 2017 | 42 | 2017 |
| Linguistic biases in letters of recommendation for radiation oncology residency applicants from 2015 to 2019 BV Chapman, MK Rooney, EB Ludmir, D De La Cruz, A Salcedo, ... Journal of Cancer Education, 1-8, 2022 | 36 | 2022 |
| Clinical pathways: a catalyst for the adoption of hypofractionation for early-stage breast cancer BV Chapman, MS Rajagopalan, DE Heron, JC Flickinger, S Beriwal International Journal of Radiation Oncology* Biology* Physics 93 (4), 854-861, 2015 | 30 | 2015 |
| Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer BV Chapman, CW Swanick, MS Ning, PK Allen, PT Soliman, SN Westin, ... Gynecologic oncology 154 (1), 22-28, 2019 | 28 | 2019 |
| Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy D Pasalic, EB Ludmir, PK Allen, NG Thaker, BV Chapman, EY Hanna, ... Radiotherapy and Oncology 148, 258-266, 2020 | 26 | 2020 |
| Primary radiotherapy for nonsurgically managed Stage I endometrial cancer: Utilization and impact of brachytherapy BS Gill, BV Chapman, KJ Hansen, P Sukumvanich, S Beriwal Brachytherapy 14 (3), 373-379, 2015 | 25 | 2015 |
| Single institution experience of proton and photon-based postoperative radiation therapy for non–small-cell lung cancer D Boyce-Fappiano, QN Nguyen, BV Chapman, PK Allen, O Gjyshi, ... Clinical Lung Cancer 22 (5), e745-e755, 2021 | 21 | 2021 |
| Estimating PTV margins in head and neck stereotactic ablative radiation therapy (SABR) through target site analysis of positioning and intrafractional accuracy S Mesko, H Wang, S Tung, C Wang, D Pasalic, BV Chapman, AC Moreno, ... International Journal of Radiation Oncology* Biology* Physics 106 (1), 185-193, 2020 | 19 | 2020 |
| Low incidence of late failure and toxicity after spine stereotactic radiosurgery: secondary analysis of phase I/II trials with long-term follow-up MS Ning, BJ Deegan, JC Ho, BV Chapman, AJ Bishop, PK Allen, ... Radiotherapy and Oncology 138, 80-85, 2019 | 17 | 2019 |
| Molecular determinants of head and neck cancer B Burtness, EA Golemis Springer, 2014 | 15 | 2014 |
| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013; 3 (7): 761–769. doi: 10.1158/2159-8290 VW Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ... CD-13-0103.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 15 | |
| Investigation of autosegmentation techniques on T2‐weighted MRI for off‐line dose reconstruction in MR‐linac workflow for head and neck cancers BA McDonald, CE Cardenas, N O'Connell, S Ahmed, MA Naser, ... Medical physics 51 (1), 278-291, 2024 | 14 | 2024 |
| Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov. 2013; 3 (7): 761–9 VW Lui, ML Hedberg, H Li, BS Vangara, K Pendleton, Y Zeng, Y Lu, ... This study analyzed whole-exome sequencing data from 151, 0 | 14 | |
